Aurora Cannabis Saves $2.6 Million in Interest Payments Through Repurchase of Convertible Senior Notes
LOS ANGELES– Canadian cannabis company Aurora Cannabis Inc. has announced that it has repurchased approximately $46.6 million (US$34.3 million) worth of its convertible senior notes. The Notes were repurchased at a total cost, including accrued interest, of $45.6 million (US$33.6 million) in cash, resulting in savings of $2.6 million in annualized interest payments. The purpose of the transaction was to reduce the company’s debt and annual cash interest costs, demonstrating Aurora’s commitment to financial discipline. The company has repurchased around $366 million (US$269 million) principal amount of its convertible senior notes since December 2021, which has resulted in annual cash interest savings of around $20 million (US$15 million).
Following completion of this repurchase, Aurora will have approximately $103 million (US$76 million) of Notes outstanding. Despite the reduction in debt, Aurora’s balance sheet remains one of the strongest in the Canadian cannabis industry. The company had achieved the goal of Adjusted EBITDA Profitability for the quarter ended December 31, 2022, and Aurora expects to continue focusing on profitable growth in both global medical and Canadian adult use markets.
The Notes were repurchased at a 2.5% discount to par value, which is the nominal value of a bond or stock. The company’s balance sheet will be further strengthened by this transaction, which is in line with Aurora’s ongoing efforts to improve its financial position. The announcement does not constitute an offer to sell, solicitation, or sale in any jurisdiction in which such offering would be unlawful.
Latest News
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...